BIOMAT Database Logo BIOMAT Database Logo

Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application. 2023

Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
Department of Oncology Radiotherapy, Jiangxi Cancer Hospital, Nanchang, China.

Amphotericin B (AmB) is regarded as a first-line therapy against life-threatening invasive fungal infections. Due to its poor oral bioavailability, AmB is restricted to intravenous administration in clinical practice. As science continues to move forward, two lipid-based formulations are successfully developed for oral AmB administration, currently undergoing phase I clinical trials. Encouragingly, lipid-AmB conjugates with emulsions also exhibit a better bioavailability, which may be another strategy to design oral AmB formulation in clinical practice. Thus, this review mainly focused on the two lipid-based formulations in clinical trials, and discussed the potential perspectives of AmB-lipid conjugation-loaded nanocochleates and emulsions.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D004655 Emulsions Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES. Emulsion
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D018942 Macrolides A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties. Macrolide

Related Publications

Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration.
October 2011, Journal of biomedical nanotechnology,
Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
Cochleate formulations of Amphotericin b designed for oral administration using a naturally occurring phospholipid.
June 2021, International journal of pharmaceutics,
Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B.
August 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
Administration of amphotericin B in lipid emulsion.
May 1997, Critical care medicine,
Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
Administration of amphotericin B in lipid emulsion.
May 1997, Critical care medicine,
Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
Oral administration of solubilized amphotericin B.
July 1961, The New England journal of medicine,
Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.
July 2009, The Journal of antimicrobial chemotherapy,
Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.
December 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
Formulation of amphotericin B as nanosuspension for oral administration.
March 2003, International journal of pharmaceutics,
Xiaoming Zhong, and Jianqiong Yang, and Hongyan Liu, and Zhiwen Yang, and Ping Luo
Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats.
September 2013, Drug development and industrial pharmacy,
Copied contents to your clipboard!